CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Tampa General Hospital

Kimberly Atrubin, Director, Infection Prevention

Take Advantage of Technology in Infection Prevention!

Kimberly Atrubin

Kimberly Atrubin

At Tampa General Hospital, we think about the importance of technology in infection prevention (IP), all the time. The health and safety of our patients always come first. I’m overwhelmed with the sheer volume of products and topics available when I really think about it.


The variety of innovation and tech has increased, especially since the arrival of COVID-19. However, the biggest bang for your buck is to consider rehauling your IP department from the inside out. Those within healthcare who didn’t know who we are or what we do certainly do now!


COVID has truly highlighted the importance and significance of infection preventionists. Requests for IP involvement have increased, which is wonderful. It is great to see the variety of departments that are truly interested in partnering with IP and no longer see us as a “clinician with a clipboard.” With these increasing demands including regulatory requirements, how do we move forward with our ultimate mission of preventing healthcare-associated infections, with limited resources?


We are a data-driven department with extensive regulatory reporting, and surveillance of process and outcome measures. What can you do to free up the infection preventionists’ time? The addition of a new team member isn’t always the answer. It is critical to reassess practices and workflows. 


Best practices reflect infection preventionists physically being out on the floors, not trapped in the office at their desk. Being out and about talking to staff is the most beneficial aspect of IP, and truly has the biggest impact on healthcare practices. This day-to-day relationship building is vital. It is opportunity to observe practices and processes. There are educational moments that will be retained compared to watching a virtual educational sessional. During times of crisis, it is these relationships and trusted partners which prove to be invaluable.


Consider the following questions:


• What can you automate that you are not currently doing? 


• Do they know how to take advantage of email and scheduling technology?


• What electronic medical records and infection prevention surveillance systems do you have, and are you using them to the best of their abilities? Are your versions outdated?


• Do your IPs have real-time alerting instead of manually pulling reports?


• Does it take hours to create slides and presentations?


• Do your infection preventionists take hours to notify reportable diseases to health departments?  Have you implemented Electronic Lab Reporting?


• Can you exclude negative labs to help eliminate “white noise” from their lab reviews?


Chart reviews for healthcare-associated infections are time-consuming. We cannot always remove duties, but we can shorten the time we spend on each. Try shifting to a more proactive approach with real-time reporting. 


This allows the IP to respond in a timely manner and perhaps actually prevent an infection, instead of reporting one. Remember, we are now called infection prevention for a reason, not infection control.  If your IP teams are dependent upon manually pulling reports, important data may only be viewed daily, which may put them a day behind actionable response. Communication tools are also important. With large workloads, your IPs must be organized. Not all IPs are tech savvy, so it is important they understand how to take advantage of all the bells and whistles that your various system offers, including programs for email and meeting scheduling. Most importantly, take advantage of your younger generation of IPs who bring fresh ideas and technological skills. 


At Tampa General Hospital, our vision is to become the safest and most innovative academic medical center in the country. Blending safety and technology has prompted our IP department to develop an automated (Qlik) Dashboard with our process and outcome data. Data will automatically pull from our various databases. This saves time in uploading, updating, and manipulating data. The goal of the dashboard will be to automate manual practices and even automate email communication and visual data presentations.


COVID has truly highlighted the importance and significance of infection preventionists


Other technology elements that impact the infection prevention department are the tools and databases that collect observations and audits. Multiple databases mean leaders and individual users need to learn multiple platforms, remember multiple passwords and develop multiple workflows. IP must manually combine data from multiple databases for reporting purposes. Consider transitioning to a single, user-friendly platform to compile all your audit and observation needs.


My final recommendation for all infection prevention departments would be investing in a data analyst. IP departments across the country are including these individuals more frequently, and it is no surprise. They bring technological skills and capabilities to the department and can quickly react to their fast-paced needs. When you have a suspected outbreak in one of your intensive care units, this team member can get you a detailed line list for quick review and response.


It is now more important than ever that healthcare departments be nimble, agile, and efficient.  Infection prevention departments are no different. Efficiency allows us to achieve our goal of giving back the IP time – time for valuable conversations, process observations and educational moments with all persons entering our healthcare facilities, including providers, team members and patients. This will ultimately prevent infections and improve patient safety.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://infection-control.lifesciencesreview.com/leadership-perspective/take-advantage-of-technology-in-infection-prevention-nwid-920.html